Epclusa
Gilead Subsidiary to Launch Generic HCV Drugs
The list price of authorized generics to reflect discounts in the system today.
SEPTEMBER 26, 2018
FDA Expands Indication Labeling for Epclusa to Treat Chronic HCV in HIV Coinfected Patients
The FDA approved updated labeling for Epclusa, the first all-oral, pan-genotypic, once-daily single-tablet regimen ...
AUGUST 2, 2017
FDA Approves Epclusa To Treat All Genotypes of HCV
Epclusa is the first and only all-oral, pangenotypic single-tablet regimen for chronic HCV.
JUNE 29, 2016
Load more